Ligand · QTN
QTN · (3~{R},3~{a}~{R},6~{R},6~{a}~{R})-6-[[6-chloranyl-5-[4-[4-[[dimethyl(oxidanyl)-$l^{4}-sulfanyl]amino]phenyl]phenyl]-3~{H}-imidazo[4,5-b]pyridin-2-yl]oxy]-2,3,3~{a},5,6,6~{a}-hexahydrofuro[3,2-b]furan-3-ol
QTN, (3~{R},3~{a}~{R},6~{R},6~{a}~{R})-6-[[6-chloranyl-5-[4-[4-[[dimethyl(oxidanyl)-$l^{4}-sulfanyl]amino]phenyl]phenyl]-3~{H}-imidazo[4,5-b]pyridin-2-yl]oxy]-2,3,3~{a},5,6,6~{a}-hexahydrofuro[3,2-b]furan-3-ol (C26 H27 Cl N4 O5 S, 543.0…
- Component
- QTN
- Formula
- C26 H27 Cl N4 O5 S
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
QTN in 1 structure; the first of them:
- 8BIK · Crystal structure of human AMPK heterotrimer in complex with allosteric activator C455 · QTN A1002 · binds VAL11, LEU18, GLY19, ASP20, PHE27, GLY28, LYS29, LYS31 and 14 more
Residues it binds most
LYS 2, VAL 2, ARG 2, ASN 2, ASP 2, GLY 2, ILE 2, LEU 2, PHE 2, SEP 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.